297 related articles for article (PubMed ID: 21116835)
21. COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells.
Fujita M; Kohanbash G; Fellows-Mayle W; Hamilton RL; Komohara Y; Decker SA; Ohlfest JR; Okada H
Cancer Res; 2011 Apr; 71(7):2664-74. PubMed ID: 21324923
[TBL] [Abstract][Full Text] [Related]
22. Erythropoietin augments survival of glioma cells after radiation and temozolomide.
Hassouna I; Sperling S; Kim E; Schulz-Schaeffer W; Rave-Fränk M; Hasselblatt M; Jelkmann W; Giese A; Ehrenreich H
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):927-34. PubMed ID: 19014782
[TBL] [Abstract][Full Text] [Related]
23. Comparison of corticotropin-releasing factor, dexamethasone, and temozolomide: treatment efficacy and toxicity in U87 and C6 intracranial gliomas.
Moroz MA; Huang R; Kochetkov T; Shi W; Thaler H; de Stanchina E; Gamez I; Ryan RP; Blasberg RG
Clin Cancer Res; 2011 May; 17(10):3282-92. PubMed ID: 21385926
[TBL] [Abstract][Full Text] [Related]
24. Temozolomide-induced modification of the CXC chemokine network in experimental gliomas.
Bruyère C; Mijatovic T; Lonez C; Spiegl-Kreinecker S; Berger W; Kast RE; Ruysschaert JM; Kiss R; Lefranc F
Int J Oncol; 2011 May; 38(5):1453-64. PubMed ID: 21399866
[TBL] [Abstract][Full Text] [Related]
25. Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis and radiosensitization, and overcomes temozolomide resistance in malignant gliomas.
Germano IM; Emdad L; Qadeer ZA; Binello E; Uzzaman M
Cancer Gene Ther; 2010 Sep; 17(9):664-74. PubMed ID: 20523363
[TBL] [Abstract][Full Text] [Related]
26. Perillyl alcohol for the treatment of temozolomide-resistant gliomas.
Cho HY; Wang W; Jhaveri N; Torres S; Tseng J; Leong MN; Lee DJ; Goldkorn A; Xu T; Petasis NA; Louie SG; Schönthal AH; Hofman FM; Chen TC
Mol Cancer Ther; 2012 Nov; 11(11):2462-72. PubMed ID: 22933703
[TBL] [Abstract][Full Text] [Related]
27. [Intranasal administration of temozolomide for brain-targeting delivery: therapeutic effect on glioma in rats].
Li Y; Gao Y; Liu G; Zhou X; Wang Y; Wang Y; Ma L
Nan Fang Yi Ke Da Xue Xue Bao; 2014 May; 34(5):631-5. PubMed ID: 24849425
[TBL] [Abstract][Full Text] [Related]
28. Blockade of Cell Volume Regulatory Protein NKCC1 Increases TMZ-Induced Glioma Apoptosis and Reduces Astrogliosis.
Luo L; Guan X; Begum G; Ding D; Gayden J; Hasan MN; Fiesler VM; Dodelson J; Kohanbash G; Hu B; Amankulor NM; Jia W; Castro MG; Sun B; Sun D
Mol Cancer Ther; 2020 Jul; 19(7):1550-1561. PubMed ID: 32393472
[TBL] [Abstract][Full Text] [Related]
29. Gene expression profiling predicts response to temozolomide in malignant gliomas.
Yoshino A; Ogino A; Yachi K; Ohta T; Fukushima T; Watanabe T; Katayama Y; Okamoto Y; Naruse N; Sano E; Tsumoto K
Int J Oncol; 2010 Jun; 36(6):1367-77. PubMed ID: 20428759
[TBL] [Abstract][Full Text] [Related]
30. Beneficial impact of CCL2 and CCL12 neutralization on experimental malignant pleural effusion.
Marazioti A; Kairi CA; Spella M; Giannou AD; Magkouta S; Giopanou I; Papaleonidopoulos V; Kalomenidis I; Snyder LA; Kardamakis D; Stathopoulos GT
PLoS One; 2013; 8(8):e71207. PubMed ID: 23967166
[TBL] [Abstract][Full Text] [Related]
31. Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.
Aghi M; Rabkin S; Martuza RL
J Natl Cancer Inst; 2006 Jan; 98(1):38-50. PubMed ID: 16391370
[TBL] [Abstract][Full Text] [Related]
32. Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response.
Yin P; Li H; Ke C; Cao G; Xin X; Hu J; Cai X; Li L; Liu X; Du B
Int J Nanomedicine; 2020; 15():1499-1515. PubMed ID: 32189965
[TBL] [Abstract][Full Text] [Related]
33. Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway.
Chio CC; Tai YT; Mohanraj M; Liu SH; Yang ST; Chen RM
Phytomedicine; 2018 Oct; 49():41-51. PubMed ID: 30217261
[TBL] [Abstract][Full Text] [Related]
34. Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive glioma.
Ni XR; Guo CC; Yu YJ; Yu ZH; Cai HP; Wu WC; Ma JX; Chen FR; Wang J; Chen ZP
Cancer Chemother Pharmacol; 2020 Dec; 86(6):773-782. PubMed ID: 33074386
[TBL] [Abstract][Full Text] [Related]
35. Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma.
Brada M; Stenning S; Gabe R; Thompson LC; Levy D; Rampling R; Erridge S; Saran F; Gattamaneni R; Hopkins K; Beall S; Collins VP; Lee SM
J Clin Oncol; 2010 Oct; 28(30):4601-8. PubMed ID: 20855843
[TBL] [Abstract][Full Text] [Related]
36. Dynamic stroma reorganization drives blood vessel dysmorphia during glioma growth.
Mathivet T; Bouleti C; Van Woensel M; Stanchi F; Verschuere T; Phng LK; Dejaegher J; Balcer M; Matsumoto K; Georgieva PB; Belmans J; Sciot R; Stockmann C; Mazzone M; De Vleeschouwer S; Gerhardt H
EMBO Mol Med; 2017 Dec; 9(12):1629-1645. PubMed ID: 29038312
[TBL] [Abstract][Full Text] [Related]
37. Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals.
Wang W; Sivakumar W; Torres S; Jhaveri N; Vaikari VP; Gong A; Howard A; Golden EB; Louie SG; Schönthal AH; Hofman FM; Chen TC
Neurosurg Focus; 2015 Mar; 38(3):E8. PubMed ID: 25727230
[TBL] [Abstract][Full Text] [Related]
38. Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-π-activated nitric oxide donor PABA/NO in malignant gliomas.
Kogias E; Osterberg N; Baumer B; Psarras N; Koentges C; Papazoglou A; Saavedra JE; Keefer LK; Weyerbrock A
Int J Cancer; 2012 Mar; 130(5):1184-94. PubMed ID: 21455987
[TBL] [Abstract][Full Text] [Related]
39. Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells.
Fridlender ZG; Kapoor V; Buchlis G; Cheng G; Sun J; Wang LC; Singhal S; Snyder LA; Albelda SM
Am J Respir Cell Mol Biol; 2011 Feb; 44(2):230-7. PubMed ID: 20395632
[TBL] [Abstract][Full Text] [Related]
40. Modulation of KCa channels increases anticancer drug delivery to brain tumors and prolongs survival in xenograft model.
Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats TS
Cancer Biol Ther; 2009 Oct; 8(20):1924-33. PubMed ID: 19738431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
